Fundraising FoxProspection
3 known investors
Find your way into Prospection
Sign up to see every warm intro you have to Prospection
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prospection team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Prospection turns longitudinal patient and real-world claims data into analytics that map the complete patient journey and predict likely next steps, using a proprietary transformer-based AI architecture. It serves pharmaceutical companies, supporting commercial and clinical decision-making across the drug lifecycle and more than 90 indications.
Investors · 3
Glitch Capitallisted by Glitch Capital
How we know: Glitch Capital's portfolio page · Not right? Tell us
Main Sequence Ventureslisted by Main Sequence VenturesSydneyvia Bill Bartee · led
How we know: Main Sequence Ventures's portfolio page · Not right? Tell us
Blackbird VenturesreportedSydney · $149K – $60M
How we know: a partner's Signal profile · Not right? Tell us
In the news
Frequently asked questions
- What does Prospection do?
- Prospection turns longitudinal patient and real-world claims data into analytics that map the complete patient journey and predict likely next steps, using a proprietary transformer-based AI architecture. It serves pharmaceutical companies, supporting commercial and clinical decision-making across the drug lifecycle and more than 90 indications.
- Who are Prospection's investors?
- Prospection's investors include Glitch Capital, Main Sequence Ventures, Blackbird Ventures.